Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.

Akshay ShahKillian DonovanAnna McHughManish PandeyLouise AaronCharlotte A BradburySimon J StanworthRaza AlikhanStephen Von KierKeith MaherNicola CurrySusan ShapiroMatthew J RowlandMatt ThomasRichard MasonMatthew HollandTom HolmesMichael WareStefan GurneyStuart R McKechnie

Published in: Critical care (London, England) (2020)

Critically ill patients with COVID-19 experience high rates of venous and arterial thrombotic complications. The rates of bleeding may be higher than previously reported and re-iterate the need for randomised trials to better understand the risk-benefit ratio of different anticoagulation strategies.

Keyphrases

clinical trial
atrial fibrillation
study protocol
double blind
risk factors
open label
venous thromboembolism
randomized controlled trial
placebo controlled
cross sectional